In a recent study, more than 40% of patients with relapsed or refractory germ cell tumors experienced a clinical benefit with cabozantinib.
Can fragments of tumor DNA in the blood predict whether chemotherapy will be effective? Researchers at the Princess Máxima Center investigated this question together with experts from Italy and ...
Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma. Data were available on 5,202 patients with nonseminomatous GCT ...
A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible ...
Based on the NCCN 1.2026 guidelines for the management of CSI seminoma, surveillance is strongly preferred for pT1-pT3 tumors, and the NCCN does not recommend risk-adapted treatment for CSI seminoma ...
Although pediatric cancer is rare, it is the leading cause of death by disease in children, according to the National Institutes of Health (NIH). Over 16,000 children in the United States are ...
Can fragments of tumor DNA in the blood predict whether chemotherapy will be effective? Researchers at the Princess Máxima Center investigated this question together with experts from Italy and ...
Malignant ovarian germ cell tumors are rare neoplasms that predominantly affect adolescents and young women. These tumours, while highly aggressive if untreated, generally respond well to therapy, ...
The difference in the odds of development of bleomycin pulmonary toxicity in patients with germ cell tumors and Hodgkin’s lymphoma receiving granulocyte colony-stimulating factor alongside bleomycin ...
A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible ...
Doctors at Children’s Hospital 2 in Ho Chi Minh City successfully removed a rare 1.3kg retroperitoneal germ cell tumor from a six-month-old boy after a complex five-hour surgery.